专家介绍
Amanda Gwee教授
墨尔本皇家儿童医院墨尔本大学
简介查看日程
Guideline/quality committees: World Health Organization (WHO) Antimicrobial Resistance Expert Group for the
WHO Global AMR research agenda (2023-); Guideline Writing Group, Therapeutic Guidelines Papua New
Guinea (2023-); Safer Care Victoria ‘Reducing Antibiotic Prescribing in Children’ Project (2022-); NHMRC
Staying Healthy Committee (2022-); European Society for Pediatric Infectious Diseases Guideline Committee
(2022-); DHHS COVID-19 Early Therapies Working Group (2022); Therapeutic Guidelines, Antibiotic Expert
Working Group (2022-); Association of Australian Medical Research Institutes Medical Research Workforce
Project, expert working group (2021); Australian Paediatric Surveillance Unit - Herpes Simplex Virus
Surveillance, advisory committee (2021-22); Australian National COVID-19 Clinical Evidence guideline
taskforce – drug treatment panel (2020-23); Parkville Electronic Medical Record Medications Advisory Group
(2019-20); Neonatal Medicines Formulary Consensus Group (expert reviewer, 2018-); Victorian Therapeutic
Guidelines developing countries program, expert clinician register (2017-)
Journal editor: Archives of Diseases in Childhood (2022-); Journal of Paediatrics and Child Health (2016 -)
Grant reviewer: NHMRC (2023, 2022, 2021, 2018, 2017); UoM Melbourne Medical School Strategic Grant for
Outstanding Women (2021); Women & Children’s Hospital Foundation grant (2019, 2017, 2014)
Clinical trial Data Safety Monitoring Board: Resveratrol study in Friedreich ataxia (2019-)
Journal reviewer: 16 journals including JAMA pediatrics, Clinical Microbiology & Infection, Journal of
Antimicrobial Chemotherapy, PLOS ONE, International Journal of Tuberculosis & Lung Disease
Research review panel: MCRI NHMRC investigator grant internal review panel (2021); UoM Melbourne Medical
School internal research review panel (2020-22)